查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
全球大腸直腸癌篩檢市場規模、佔有率、行業趨勢分析報告：按類型、最終用戶、地區分類的展望和預測，2023-2030年
市場調查報告書
商品編碼
1353109

全球大腸直腸癌篩檢市場規模、佔有率、行業趨勢分析報告：按類型、最終用戶、地區分類的展望和預測，2023-2030年

Global Colorectal Cancer Screening Market Size, Share & Industry Trends Analysis Report By Type (Colonoscopy, Stool-based), By End-user, By Regional Outlook and Forecast, 2023 - 2030
出版日期: | 出版商: KBV Research | 英文 263 Pages | 訂單完成後即時交付

價格

到 2030 年，大腸直腸癌篩檢市場規模預計將達到 222 億美元，預測期內年複合成長率為 4.8%。

根據 KBV 基數矩陣中的分析，Siemens Hertinius AG 是市場先驅。 2021年4月，西門子收購瓦里安醫療系統，增強了西門子醫療的競爭力與獨立性。FUJIFILM Holdings公司、奧林巴斯公司和生物梅里埃公司等公司是市場上的主要創新者。

COVID-19 影響分析

由於COVID-19的影響，疫情期間市場成長放緩。大流行時期的封鎖限制和腸癌篩檢的取消導致了這一點。 2020 年，許多國家完全停止了內視鏡篩檢，以減少人與人之間的接觸，並為接觸 COVID-19 的人節省醫院和醫療資源。疫情期間，市場銷售成長放緩。在大流行期間，政府計劃減少了接受檢測的人數。

市場成長要素

大腸直腸癌的風險增加

全球大腸直腸癌罹患率的顯著增加是積極影響市場擴張的關鍵要素之一。由於不健康的生活方式選擇和人口爆炸性高齡化，已開發國家的罹患率最高，低收入和中等收入國家的發病率不斷上升。此外，根據美國癌症協會的數據，2020年美國將確診43,340例直腸癌新病例和104,610例結腸癌新病例。大腸直腸癌罹患率的上升和死亡率的上升增加了大腸直腸癌檢測的需求，這可能成為未來幾年及以後市場擴張的驅動力。

政府癌症篩檢政策

一些國家的政府加強了篩檢政策，以降低全球大腸癌的發生率。一些國家的政府已經實施了各種配合措施來減輕大腸癌日益增加的負擔，包括對罹患族群進行定期篩檢。根據美國國家醫學圖書館 2019 年發布的一項研究，在韓國，國家癌症篩檢計畫向所有 50 歲及以上的成年人提供免費或低成本的 CRC 篩檢。由於老年人口的增加和政府的配合措施，各種測試的使用預計會增加，從而推動整體市場的擴張。

市場抑制因素

內視鏡的不良反應可能導致引入此測試的減少

儘管對先進和高效的篩選測試的需求不斷成長，但篩選測試設備的採用可能因其固有的限制而受到阻礙。例如，內視鏡的陽性率最高，也是最準確的檢查。然而，患者在內視鏡過程中可能會出現一些副作用，例如出血和感染。與大腸癌篩檢技術相關的這些限制和不利影響預計將在預測期內限制市場擴張。

按類型分類的展望

依類型分為糞便檢驗、內視鏡等。到 2022 年，基於航班的細分市場將在市場中佔據重要的收入佔有率。使用糞便檢測診斷結直腸癌和癌前病變已顯示出有希望的結果，並已成為早期檢測的有用工具。一種創新的基於糞便的測試分析糞便樣本，以尋找與大腸癌相關的特定 DNA 標記。政府大腸直腸癌篩檢計畫的增加和糞便檢測效率的提高正在促進這一領域的成長。

飛行型的前景

在糞便檢測領域，市場進一步分為糞便免疫化學檢查（FIT）、大便潛血試驗（FOBT）和糞便DNA檢測。糞便免疫化學檢查(FIT) 領域在 2022 年佔據市場最大的收入佔有率。 FIT（糞便免疫化學檢查）是一種非侵入性診斷程序，用於鑒定糞便中的血液。 FIT被廣泛用作診斷工具，透過檢測糞便樣本中的血液來檢測癌前病變和早期大腸癌。 FIT 的發展重點是提高敏感性、特異性和患者友善性。

最終用戶前景

根據最終用戶，市場分為醫院和診所、臨床實驗室、影像影像中心等。 2022年，醫院和診所細分市場以最大的收入佔有率主導市場。該細分市場的成長歸因於大腸直腸癌患病的上升以及全球醫院篩檢測試的技術進步。由於醫院數量眾多等因素，醫院和診所對大腸癌篩檢的需求不斷增加。

區域展望

從區域來看，我們對北美、歐洲、亞太地區和拉丁美洲地區的市場進行了分析。 2022年，亞太地區在市場中獲得了顯著的收入佔有率。亞洲國家的市場開拓和醫療設施升級、該地區國家大腸癌罹患率的上升以及個人對更好治療結果的認知不斷提高，推動了該區域市場的擴張。此外，該地區主要國家結直腸癌罹患率的上升以及大腸直腸疾病成為主要死亡原因預計也將推動該地區的市場成長。

目錄

第1章 市場範圍和調查方法

  • 市場定義
  • 目的
  • 市場範圍
  • 分割
  • 調查方法

第2章 市場概況

  • 主要亮點

第3章 市場概況

  • 介紹
    • 概述
      • 市場結構和情景
  • 影響市場的主要要素
    • 市場促進因素
    • 市場抑制因素

第4章 競爭分析-世界

  • KBV Cardinal Matrix
  • 近期全產業策略發展
    • 夥伴關係、協作和協議
    • 產品發布和產品擴展
    • 收購和合併
    • 地理擴張
  • 關鍵成功策略
    • 主要策略
    • 重大策略舉措
  • 波特五力分析

第5章 全球大腸癌篩檢市場：依類型

  • 全球內視鏡市場：按地區
  • 全球凳基市場：按地區
  • 全球大腸癌篩檢市場：按凳基類型
    • 全球糞便免疫化學檢查(FIT) 市場：按地區
    • 全球糞便大便潛血試驗(FOBT) 市場：按地區
    • 全球糞便 DNA 檢測市場：按地區
  • 世界其他市場：按地區

第6章 全球大腸癌篩檢市場：依最終用戶分類

  • 全球醫院和診所市場：按地區
  • 全球臨床檢測市場：按地區分類
  • 全球影像影像中心市場：按地區
  • 世界其他市場：按地區

第7章 全球大腸癌篩檢市場：按地區

  • 北美洲
    • 北美市場：按國家分類
      • 美國
      • 加拿大
      • 墨西哥
      • 其他北美地區
  • 歐洲
    • 歐洲市場：依國家分類
      • 德國
      • 英國
      • 法國
      • 俄羅斯
      • 西班牙
      • 義大利
      • 其他歐洲國家地區
  • 亞太地區
    • 亞太市場：依國家分類
      • 中國
      • 日本
      • 印度
      • 韓國
      • 新加坡
      • 馬來西亞
      • 其他亞太地區
  • 拉丁美洲/中東/非洲
    • 拉丁美洲/中東/非洲市場：依國家分類
      • 巴西
      • 阿根廷
      • 阿拉伯聯合大公國
      • 沙烏地阿拉伯
      • 南非
      • 奈及利亞
      • 其他拉丁美洲/中東/非洲地區

第8章 公司簡介

  • Novigenix SA
  • Eiken Chemical Co, Ltd.
  • Clinical Genomics Pathology, Inc
  • Exact Sciences Corporation
  • Epigenomics AG
  • BioMerieux SA
  • Olympus Corporation
  • Sysmex Corporation
  • Siemens Healthineers AG（Siemens AG）
  • Fujifilm Holdings Corporation

第9章 結直腸癌篩檢市場的勝利至關重要

The Global Colorectal Cancer Screening Market size is expected to reach $22.2 billion by 2030, rising at a market growth of 4.8% CAGR during the forecast period.

In United States, approximately nine out of ten people with colorectal cancer who are diagnosed early and treated appropriately are still alive five years later. Hence, the North America region would capture approximately 2/5th of the market by 2030. Due to several factors, including an aging population, an increase in cancer cases, high healthcare spending, and a modern healthcare infrastructure. The market is also expanding due to rising government initiatives to create awareness of the disease and the accessibility of screening tests like FIT and FOBT.

The major strategies followed by the market participants are Acquisitions as the key developmental strategy in order to keep pace with the changing demands of end users. For instance, In April, 2022, BioMerieux S.A. acquired Specific Diagnostics to enhances bioMerieux's capability to deliver instant AST results by adding specific Diagnostics' SPECIFIC REVEAL Rapid AST offerings to its portfolio. In December, 2022, Olympus Corporation took over Odin Vision to reinforce Olympus' strategy for delivering digital patient care.

Based on the Analysis presented in the KBV Cardinal matrix; Siemens Healthineers AG is the forerunner in the Market. April, 2021, Siemens took over Varian Medical Systems to strengthen the competitiveness & independence of Siemens Healthineers. Companies such as Fujifilm Holdings Corporation, Olympus Corporation, BioMerieux S.A. are some of the key innovators in the Market.

COVID-19 Impact Analysis

The COVID-19 effect caused the market growth to slow down during the pandemic. Pandemic-era lockdown limitations and a suspension of colorectal cancer screening brought this on. To decrease person-to-person contact and conserve hospital and medical resources for those exposed to COVID-19, screening through colonoscopies was completely discontinued in many countries in 2020. The market slowed in growth during the pandemic period when measured by revenue. During the pandemic, there was a decrease in the number of people being examined through government programs.

Market Growth Factors

Growing Risk of Colorectal Cancer

The substantial rise in global colorectal cancer incidence is one of the key factors that favorably influence the market's expansion. The incidence is highest in developed nations, rising in middle- and low-income nations because of unhealthy lifestyle choices and an aging population explosion. Additionally, according to the American Cancer Society, 43,340 new instances of rectal cancer and 104,610 new cases of colon cancer were identified in the United States in 2020, respectively. The demand for CRC detection has increased due to the rising incidence of CRC and the disease's rising death rate, which will likely drive the expansion of the market in the following years.

Government Cancer Screening Policies

Governments in several nations have strengthened screening policies to reduce the incidence of colorectal cancer on a global scale. Governments in several nations have implemented various initiatives, such as regular screening programs for individuals at risk of contracting the disease, to reduce the growing burden of CRC. In Korea, the National Cancer Screening Program offers CRC screening to all adults over 50 at no or at a low cost, according to a study released by the National Library of Medicine in 2019. The usage of various tests is anticipated to increase due to the growing elderly population and government initiatives, which will fuel market expansion overall.

Market Restraining Factors

Negative Effects of Colonoscopies May Lead to Decreased Adoption of Testing

Despite the critical and growing need for advanced and efficient screening procedures, adopting screening devices may be hampered by their inherent limitations. A colonoscopy, for instance, has the highest incidence of positive results and is a highly accurate test. However, the patient may experience several negative side effects from the colonoscopy process, including bleeding and infection. During the forecast period, these restrictions and unfavorable effects related to colorectal cancer screening techniques are anticipated to restrain market expansion.

Type Outlook

By type, the market is segmented into stool-based, colonoscopy, and others. The stool-based segment covered a considerable revenue share in the market in 2022. The diagnosis of colorectal cancer and precancerous lesions using stool-based tests has shown encouraging results, making it a useful tool for early detection. The revolutionary stool-based tests analyze stool samples to find specific DNA markers related to colorectal cancer. Increased government programs for colorectal cancer screening and the efficiency of stool-based tests have contributed to the segment's growth.

Stool-based type Outlook

Under the stool-based segment, the market is further divided into fecal immunochemical test (FIT), fecal occult blood test (FOBT), and stool-DNA test. The fecal immunochemical test (FIT) segment witnessed the largest revenue share in the market in 2022. The FIT, or fecal immunochemical test, is a non-invasive diagnostic procedure used to identify blood in stool. FITs are extensively utilized diagnostic tools for detecting precancerous lesions or early-stage colorectal cancer by detecting blood in stool samples. The development of FITs has focused on enhancing their sensitivity, specificity, and patient friendliness.

End-user Outlook

Based on end-user, the market is bifurcated into hospital & clinics, clinical laboratories, diagnostic imaging centers, and others. In 2022, the hospitals and clinics segment dominated the market with maximum revenue share. The growth of the segment is attributable to the rise in the prevalence of colorectal cancer and technological advancements in screening tests conducted in hospitals globally. The demand for CRC screening is expanding in hospitals and clinics due to elements including a sizable number of hospitals.

Regional Outlook

Region-wise, the market is analysed across North America, Europe, Asia Pacific, and LAMEA. In 2022, the Asia Pacific region acquired a significant revenue share in the market. The expansion of the regional market is driven by the development and upgrading of healthcare facilities in Asian nations, rising CRC incidence in the region's nations, and rising individual consciousness of better treatment outcomes. It is expected that the rising incidence of colorectal cancer in the region's key countries and the status of colorectal diseases as the primary cause of mortality will also drive market growth in the region.

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Novigenix SA, Eiken Chemical Co., Ltd., Clinical Genomics Pathology, Inc., Exact Sciences Corporation, Epigenomics AG, BioMerieux S.A., Olympus Corporation, Sysmex Corporation, Fujifilm Holdings Corporation, and Siemens Healthineers AG (Siemens AG)

Strategies deployed in Colorectal Cancer Screening Market

Jul-2023: BioMerieux S.A. signed a partnership with Oxford Nanopore, a medical technology company, to provide nanopore sequencing solutions within the infectious disease diagnostics market. The partnership provides BioMerieux with opportunities for exploring new technologies for improved patient care.

Dec-2022: Olympus Corporation took over Odin Vision, an endoscopy solutions provider. The acquisition reinforces Olympus' strategy for delivering digital patient care.

Apr-2022: BioMerieux S.A. acquired Specific Diagnostics, an antimicrobial susceptibility test (AST) specialist. The acquisition enhances bioMerieux's capability to deliver instant AST results by adding specific Diagnostics' SPECIFIC REVEAL Rapid AST offerings to its portfolio.

May-2021: Fujifilm Holdings Corporation signed a partnership with Helio Health, an AI-powered healthcare solutions provider, to develop solutions for early detection of liver cancer. The partnership would provide clinicians around the world with market-leading diagnostic and surveillance technologies.

Apr-2021: Siemens took over Varian Medical Systems, a U.S. company active in the region of cancer research & therapy. This acquisition would allow Siemens to strengthen the competitiveness & independence of Siemens Healthineers. The acquisition further focused on creating a world-leading company in cancer therapy.

Jan-2021: Fujifilm Holdings Corporation expanded its geographical footprint by opening a new centre named "NURA" in Bangalore, India. The centre would serve as a medical screening service business for the company.

Scope of the Study

Market Segments covered in the Report:

By Type

  • Colonoscopy
  • Stool-based
    • Fecal Immunochemical Test (FIT)
    • Fecal Occult Blood Test (FOBT)
    • Stool-DNA Test
  • Others

By End-user

  • Hospitals & Clinics
  • Clinical Laboratories
  • Diagnostic Imaging Centres
  • Others

By Geography

  • North America
    • US
    • Canada
    • Mexico
    • Rest of North America
  • Europe
    • Germany
    • UK
    • France
    • Russia
    • Spain
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Singapore
    • Malaysia
    • Rest of Asia Pacific
  • LAMEA
    • Brazil
    • Argentina
    • UAE
    • Saudi Arabia
    • South Africa
    • Nigeria
    • Rest of LAMEA

Companies Profiled

  • Novigenix SA
  • Eiken Chemical Co., Ltd.
  • Clinical Genomics Pathology, Inc.
  • Exact Sciences Corporation
  • Epigenomics AG
  • BioMerieux S.A.
  • Olympus Corporation
  • Sysmex Corporation
  • Fujifilm Holdings Corporation
  • Siemens Healthineers AG (Siemens AG)

Unique Offerings from KBV Research

  • Exhaustive coverage
  • Highest number of market tables and figures
  • Subscription based model available
  • Guaranteed best price
  • Assured post sales research support with 10% customization free

Table of Contents

Chapter 1. Market Scope & Methodology

  • 1.1 Market Definition
  • 1.2 Objectives
  • 1.3 Market Scope
  • 1.4 Segmentation
    • 1.4.1 Global Colorectal Cancer Screening Market, by Type
    • 1.4.2 Global Colorectal Cancer Screening Market, by End-user
    • 1.4.3 Global Colorectal Cancer Screening Market, by Geography
  • 1.5 Methodology for the research

Chapter 2. Market at a Glance

  • 2.1 Key Highlights

Chapter 3. Market Overview

  • 3.1 Introduction
    • 3.1.1 Overview
      • 3.1.1.1 Market Composition and Scenario
  • 3.2 Key Factors Impacting the Market
    • 3.2.1 Market Drivers
    • 3.2.2 Market Restraints

Chapter 4. Competition Analysis - Global

  • 4.1 KBV Cardinal Matrix
  • 4.2 Recent Industry Wide Strategic Developments
    • 4.2.1 Partnerships, Collaborations and Agreements
    • 4.2.2 Product Launches and Product Expansions
    • 4.2.3 Acquisition and Mergers
    • 4.2.4 Geographical Expansions
  • 4.3 Top Winning Strategies
    • 4.3.1 Key Leading Strategies: Percentage Distribution (2019-2023)
    • 4.3.2 Key Strategic Move: (Mergers & Acquisition: 2019, Jul - 2022, Dec) Leading Players
  • 4.4 Porter's Five Forces Analysis

Chapter 5. Global Colorectal Cancer Screening Market by Type

  • 5.1 Global Colonoscopy Market by Region
  • 5.2 Global Stool-based Market by Region
  • 5.3 Global Colorectal Cancer Screening Market by Stool-based Type
    • 5.3.1 Global Fecal Immunochemical Test (FIT) Market by Region
    • 5.3.2 Global Fecal Occult Blood Test (FOBT) Market by Region
    • 5.3.3 Global Stool-DNA Test Market by Region
  • 5.4 Global Others Market by Region

Chapter 6. Global Colorectal Cancer Screening Market by End-user

  • 6.1 Global Hospitals & Clinics Market by Region
  • 6.2 Global Clinical Laboratories Market by Region
  • 6.3 Global Diagnostic Imaging Centres Market by Region
  • 6.4 Global Others Market by Region

Chapter 7. Global Colorectal Cancer Screening Market by Region

  • 7.1 North America Colorectal Cancer Screening Market
    • 7.1.1 North America Colorectal Cancer Screening Market by Type
      • 7.1.1.1 North America Colonoscopy Market by Country
      • 7.1.1.2 North America Stool-based Market by Country
      • 7.1.1.3 North America Colorectal Cancer Screening Market by Stool-based Type
        • 7.1.1.3.1 North America Fecal Immunochemical Test (FIT) Market by Country
        • 7.1.1.3.2 North America Fecal Occult Blood Test (FOBT) Market by Country
        • 7.1.1.3.3 North America Stool-DNA Test Market by Country
      • 7.1.1.4 North America Others Market by Country
    • 7.1.2 North America Colorectal Cancer Screening Market by End-user
      • 7.1.2.1 North America Hospitals & Clinics Market by Country
      • 7.1.2.2 North America Clinical Laboratories Market by Country
      • 7.1.2.3 North America Diagnostic Imaging Centres Market by Country
      • 7.1.2.4 North America Others Market by Country
    • 7.1.3 North America Colorectal Cancer Screening Market by Country
      • 7.1.3.1 US Colorectal Cancer Screening Market
        • 7.1.3.1.1 US Colorectal Cancer Screening Market by Type
        • 7.1.3.1.2 US Colorectal Cancer Screening Market by End-user
      • 7.1.3.2 Canada Colorectal Cancer Screening Market
        • 7.1.3.2.1 Canada Colorectal Cancer Screening Market by Type
        • 7.1.3.2.2 Canada Colorectal Cancer Screening Market by End-user
      • 7.1.3.3 Mexico Colorectal Cancer Screening Market
        • 7.1.3.3.1 Mexico Colorectal Cancer Screening Market by Type
        • 7.1.3.3.2 Mexico Colorectal Cancer Screening Market by End-user
      • 7.1.3.4 Rest of North America Colorectal Cancer Screening Market
        • 7.1.3.4.1 Rest of North America Colorectal Cancer Screening Market by Type
        • 7.1.3.4.2 Rest of North America Colorectal Cancer Screening Market by End-user
  • 7.2 Europe Colorectal Cancer Screening Market
    • 7.2.1 Europe Colorectal Cancer Screening Market by Type
      • 7.2.1.1 Europe Colonoscopy Market by Country
      • 7.2.1.2 Europe Stool-based Market by Country
      • 7.2.1.3 Europe Colorectal Cancer Screening Market by Stool-based Type
        • 7.2.1.3.1 Europe Fecal Immunochemical Test (FIT) Market by Country
        • 7.2.1.3.2 Europe Fecal Occult Blood Test (FOBT) Market by Country
        • 7.2.1.3.3 Europe Stool-DNA Test Market by Country
      • 7.2.1.4 Europe Others Market by Country
    • 7.2.2 Europe Colorectal Cancer Screening Market by End-user
      • 7.2.2.1 Europe Hospitals & Clinics Market by Country
      • 7.2.2.2 Europe Clinical Laboratories Market by Country
      • 7.2.2.3 Europe Diagnostic Imaging Centres Market by Country
      • 7.2.2.4 Europe Others Market by Country
    • 7.2.3 Europe Colorectal Cancer Screening Market by Country
      • 7.2.3.1 Germany Colorectal Cancer Screening Market
        • 7.2.3.1.1 Germany Colorectal Cancer Screening Market by Type
        • 7.2.3.1.2 Germany Colorectal Cancer Screening Market by End-user
      • 7.2.3.2 UK Colorectal Cancer Screening Market
        • 7.2.3.2.1 UK Colorectal Cancer Screening Market by Type
        • 7.2.3.2.2 UK Colorectal Cancer Screening Market by End-user
      • 7.2.3.3 France Colorectal Cancer Screening Market
        • 7.2.3.3.1 France Colorectal Cancer Screening Market by Type
        • 7.2.3.3.2 France Colorectal Cancer Screening Market by End-user
      • 7.2.3.4 Russia Colorectal Cancer Screening Market
        • 7.2.3.4.1 Russia Colorectal Cancer Screening Market by Type
        • 7.2.3.4.2 Russia Colorectal Cancer Screening Market by End-user
      • 7.2.3.5 Spain Colorectal Cancer Screening Market
        • 7.2.3.5.1 Spain Colorectal Cancer Screening Market by Type
        • 7.2.3.5.2 Spain Colorectal Cancer Screening Market by End-user
      • 7.2.3.6 Italy Colorectal Cancer Screening Market
        • 7.2.3.6.1 Italy Colorectal Cancer Screening Market by Type
        • 7.2.3.6.2 Italy Colorectal Cancer Screening Market by End-user
      • 7.2.3.7 Rest of Europe Colorectal Cancer Screening Market
        • 7.2.3.7.1 Rest of Europe Colorectal Cancer Screening Market by Type
        • 7.2.3.7.2 Rest of Europe Colorectal Cancer Screening Market by End-user
  • 7.3 Asia Pacific Colorectal Cancer Screening Market
    • 7.3.1 Asia Pacific Colorectal Cancer Screening Market by Type
      • 7.3.1.1 Asia Pacific Colonoscopy Market by Country
      • 7.3.1.2 Asia Pacific Stool-based Market by Country
      • 7.3.1.3 Asia Pacific Colorectal Cancer Screening Market by Stool-based Type
        • 7.3.1.3.1 Asia Pacific Fecal Immunochemical Test (FIT) Market by Country
        • 7.3.1.3.2 Asia Pacific Fecal Occult Blood Test (FOBT) Market by Country
        • 7.3.1.3.3 Asia Pacific Stool-DNA Test Market by Country
      • 7.3.1.4 Asia Pacific Others Market by Country
    • 7.3.2 Asia Pacific Colorectal Cancer Screening Market by End-user
      • 7.3.2.1 Asia Pacific Hospitals & Clinics Market by Country
      • 7.3.2.2 Asia Pacific Clinical Laboratories Market by Country
      • 7.3.2.3 Asia Pacific Diagnostic Imaging Centres Market by Country
      • 7.3.2.4 Asia Pacific Others Market by Country
    • 7.3.3 Asia Pacific Colorectal Cancer Screening Market by Country
      • 7.3.3.1 China Colorectal Cancer Screening Market
        • 7.3.3.1.1 China Colorectal Cancer Screening Market by Type
        • 7.3.3.1.2 China Colorectal Cancer Screening Market by End-user
      • 7.3.3.2 Japan Colorectal Cancer Screening Market
        • 7.3.3.2.1 Japan Colorectal Cancer Screening Market by Type
        • 7.3.3.2.2 Japan Colorectal Cancer Screening Market by End-user
      • 7.3.3.3 India Colorectal Cancer Screening Market
        • 7.3.3.3.1 India Colorectal Cancer Screening Market by Type
        • 7.3.3.3.2 India Colorectal Cancer Screening Market by End-user
      • 7.3.3.4 South Korea Colorectal Cancer Screening Market
        • 7.3.3.4.1 South Korea Colorectal Cancer Screening Market by Type
        • 7.3.3.4.2 South Korea Colorectal Cancer Screening Market by End-user
      • 7.3.3.5 Singapore Colorectal Cancer Screening Market
        • 7.3.3.5.1 Singapore Colorectal Cancer Screening Market by Type
        • 7.3.3.5.2 Singapore Colorectal Cancer Screening Market by End-user
      • 7.3.3.6 Malaysia Colorectal Cancer Screening Market
        • 7.3.3.6.1 Malaysia Colorectal Cancer Screening Market by Type
        • 7.3.3.6.2 Malaysia Colorectal Cancer Screening Market by End-user
      • 7.3.3.7 Rest of Asia Pacific Colorectal Cancer Screening Market
        • 7.3.3.7.1 Rest of Asia Pacific Colorectal Cancer Screening Market by Type
        • 7.3.3.7.2 Rest of Asia Pacific Colorectal Cancer Screening Market by End-user
  • 7.4 LAMEA Colorectal Cancer Screening Market
    • 7.4.1 LAMEA Colorectal Cancer Screening Market by Type
      • 7.4.1.1 LAMEA Colonoscopy Market by Country
      • 7.4.1.2 LAMEA Stool-based Market by Country
      • 7.4.1.3 LAMEA Colorectal Cancer Screening Market by Stool-based Type
        • 7.4.1.3.1 LAMEA Fecal Immunochemical Test (FIT) Market by Country
        • 7.4.1.3.2 LAMEA Fecal Occult Blood Test (FOBT) Market by Country
        • 7.4.1.3.3 LAMEA Stool-DNA Test Market by Country
      • 7.4.1.4 LAMEA Others Market by Country
    • 7.4.2 LAMEA Colorectal Cancer Screening Market by End-user
      • 7.4.2.1 LAMEA Hospitals & Clinics Market by Country
      • 7.4.2.2 LAMEA Clinical Laboratories Market by Country
      • 7.4.2.3 LAMEA Diagnostic Imaging Centres Market by Country
      • 7.4.2.4 LAMEA Others Market by Country
    • 7.4.3 LAMEA Colorectal Cancer Screening Market by Country
      • 7.4.3.1 Brazil Colorectal Cancer Screening Market
        • 7.4.3.1.1 Brazil Colorectal Cancer Screening Market by Type
        • 7.4.3.1.2 Brazil Colorectal Cancer Screening Market by End-user
      • 7.4.3.2 Argentina Colorectal Cancer Screening Market
        • 7.4.3.2.1 Argentina Colorectal Cancer Screening Market by Type
        • 7.4.3.2.2 Argentina Colorectal Cancer Screening Market by End-user
      • 7.4.3.3 UAE Colorectal Cancer Screening Market
        • 7.4.3.3.1 UAE Colorectal Cancer Screening Market by Type
        • 7.4.3.3.2 UAE Colorectal Cancer Screening Market by End-user
      • 7.4.3.4 Saudi Arabia Colorectal Cancer Screening Market
        • 7.4.3.4.1 Saudi Arabia Colorectal Cancer Screening Market by Type
        • 7.4.3.4.2 Saudi Arabia Colorectal Cancer Screening Market by End-user
      • 7.4.3.5 South Africa Colorectal Cancer Screening Market
        • 7.4.3.5.1 South Africa Colorectal Cancer Screening Market by Type
        • 7.4.3.5.2 South Africa Colorectal Cancer Screening Market by End-user
      • 7.4.3.6 Nigeria Colorectal Cancer Screening Market
        • 7.4.3.6.1 Nigeria Colorectal Cancer Screening Market by Type
        • 7.4.3.6.2 Nigeria Colorectal Cancer Screening Market by End-user
      • 7.4.3.7 Rest of LAMEA Colorectal Cancer Screening Market
        • 7.4.3.7.1 Rest of LAMEA Colorectal Cancer Screening Market by Type
        • 7.4.3.7.2 Rest of LAMEA Colorectal Cancer Screening Market by End-user

Chapter 8. Company Profiles

  • 8.1 Novigenix SA
    • 8.1.1 Company Overview
    • 8.1.2 SWOT Analysis
  • 8.2 Eiken Chemical Co., Ltd.
    • 8.2.1 Company Overview
    • 8.2.2 Financial Analysis
    • 8.2.3 Research & Development Expenses
  • 8.3 Clinical Genomics Pathology, Inc.
    • 8.3.1 Company Overview
    • 8.3.2 Recent strategies and developments:
      • 8.3.2.1 Partnerships, Collaborations, and Agreements:
    • 8.3.3 SWOT Analysis
  • 8.4 Exact Sciences Corporation
    • 8.4.1 Company Overview
    • 8.4.2 Financial Analysis
    • 8.4.3 Regional Analysis
    • 8.4.4 Research & Development Expenses
    • 8.4.5 Recent strategies and developments:
      • 8.4.5.1 Acquisition and Mergers:
    • 8.4.6 SWOT Analysis
  • 8.5 Epigenomics AG
    • 8.5.1 Company Overview
    • 8.5.2 Financial Analysis
    • 8.5.3 Regional Analysis
    • 8.5.4 Research & Development Expenses
    • 8.5.5 SWOT Analysis
  • 8.6 BioMerieux S.A.
    • 8.6.1 Company Overview
    • 8.6.2 Financial Analysis
    • 8.6.3 Segmental and Regional Analysis
    • 8.6.4 Research & Development Expenses
    • 8.6.5 Recent strategies and developments:
      • 8.6.5.1 Partnerships, Collaborations, and Agreements:
      • 8.6.5.2 Acquisition and Mergers:
    • 8.6.6 SWOT Analysis
  • 8.7 Olympus Corporation
    • 8.7.1 Company Overview
    • 8.7.2 Financial Analysis
    • 8.7.3 Segmental and Regional Analysis
    • 8.7.4 Research & Development Expenses
    • 8.7.5 Recent strategies and developments:
      • 8.7.5.1 Partnerships, Collaborations, and Agreements:
      • 8.7.5.2 Product Launches and Product Expansions:
      • 8.7.5.3 Acquisition and Mergers:
    • 8.7.6 SWOT Analysis
  • 8.8 Sysmex Corporation
    • 8.8.1 Company Overview
    • 8.8.2 Financial Analysis
    • 8.8.3 Regional Analysis
    • 8.8.4 Research & Development Expense
    • 8.8.5 SWOT Analysis
  • 8.9 Siemens Healthineers AG (Siemens AG)
    • 8.9.1 Company Overview
    • 8.9.2 Financial Analysis
    • 8.9.3 Segmental and Regional Analysis
    • 8.9.4 Research & Development Expense
      • 8.9.4.1 Acquisition and Mergers:
    • 8.9.5 SWOT Analysis
  • 8.10. Fujifilm Holdings Corporation
    • 8.10.1 Company Overview
    • 8.10.2 Financial Analysis
    • 8.10.3 Segmental and Regional Analysis
    • 8.10.4 Research & Development Expenses
    • 8.10.5 Recent strategies and developments:
      • 8.10.5.1 Partnerships, Collaborations, and Agreements:
      • 8.10.5.2 Product Launches and Product Expansions:
      • 8.10.5.3 Geographical Expansions:
    • 8.10.6 SWOT Analysis

Chapter 9. Winning Imperative for Colorectal Cancer Screening Market

LIST OF TABLES

  • TABLE 1 Global Colorectal Cancer Screening Market, 2019 - 2022, USD Million
  • TABLE 2 Global Colorectal Cancer Screening Market, 2023 - 2030, USD Million
  • TABLE 3 Partnerships, Collaborations and Agreements- Colorectal Cancer Screening Market
  • TABLE 4 Product Launches And Product Expansions- Colorectal Cancer Screening Market
  • TABLE 5 Acquisition and Mergers- Colorectal Cancer Screening Market
  • TABLE 6 Geographical Expansions- Colorectal Cancer Screening Market
  • TABLE 7 Global Colorectal Cancer Screening Market by Type, 2019 - 2022, USD Million
  • TABLE 8 Global Colorectal Cancer Screening Market by Type, 2023 - 2030, USD Million
  • TABLE 9 Global Colonoscopy Market by Region, 2019 - 2022, USD Million
  • TABLE 10 Global Colonoscopy Market by Region, 2023 - 2030, USD Million
  • TABLE 11 Global Stool-based Market by Region, 2019 - 2022, USD Million
  • TABLE 12 Global Stool-based Market by Region, 2023 - 2030, USD Million
  • TABLE 13 Global Colorectal Cancer Screening Market by Stool-based Type, 2019 - 2022, USD Million
  • TABLE 14 Global Colorectal Cancer Screening Market by Stool-based Type, 2023 - 2030, USD Million
  • TABLE 15 Global Fecal Immunochemical Test (FIT) Market by Region, 2019 - 2022, USD Million
  • TABLE 16 Global Fecal Immunochemical Test (FIT) Market by Region, 2023 - 2030, USD Million
  • TABLE 17 Global Fecal Occult Blood Test (FOBT) Market by Region, 2019 - 2022, USD Million
  • TABLE 18 Global Fecal Occult Blood Test (FOBT) Market by Region, 2023 - 2030, USD Million
  • TABLE 19 Global Stool-DNA Test Market by Region, 2019 - 2022, USD Million
  • TABLE 20 Global Stool-DNA Test Market by Region, 2023 - 2030, USD Million
  • TABLE 21 Global Others Market by Region, 2019 - 2022, USD Million
  • TABLE 22 Global Others Market by Region, 2023 - 2030, USD Million
  • TABLE 23 Global Colorectal Cancer Screening Market by End-user, 2019 - 2022, USD Million
  • TABLE 24 Global Colorectal Cancer Screening Market by End-user, 2023 - 2030, USD Million
  • TABLE 25 Global Hospitals & Clinics Market by Region, 2019 - 2022, USD Million
  • TABLE 26 Global Hospitals & Clinics Market by Region, 2023 - 2030, USD Million
  • TABLE 27 Global Clinical Laboratories Market by Region, 2019 - 2022, USD Million
  • TABLE 28 Global Clinical Laboratories Market by Region, 2023 - 2030, USD Million
  • TABLE 29 Global Diagnostic Imaging Centres Market by Region, 2019 - 2022, USD Million
  • TABLE 30 Global Diagnostic Imaging Centres Market by Region, 2023 - 2030, USD Million
  • TABLE 31 Global Others Market by Region, 2019 - 2022, USD Million
  • TABLE 32 Global Others Market by Region, 2023 - 2030, USD Million
  • TABLE 33 Global Colorectal Cancer Screening Market by Region, 2019 - 2022, USD Million
  • TABLE 34 Global Colorectal Cancer Screening Market by Region, 2023 - 2030, USD Million
  • TABLE 35 North America Colorectal Cancer Screening Market, 2019 - 2022, USD Million
  • TABLE 36 North America Colorectal Cancer Screening Market, 2023 - 2030, USD Million
  • TABLE 37 North America Colorectal Cancer Screening Market by Type, 2019 - 2022, USD Million
  • TABLE 38 North America Colorectal Cancer Screening Market by Type, 2023 - 2030, USD Million
  • TABLE 39 North America Colonoscopy Market by Country, 2019 - 2022, USD Million
  • TABLE 40 North America Colonoscopy Market by Country, 2023 - 2030, USD Million
  • TABLE 41 North America Stool-based Market by Country, 2019 - 2022, USD Million
  • TABLE 42 North America Stool-based Market by Country, 2023 - 2030, USD Million
  • TABLE 43 North America Colorectal Cancer Screening Market by Stool-based Type, 2019 - 2022, USD Million
  • TABLE 44 North America Colorectal Cancer Screening Market by Stool-based Type, 2023 - 2030, USD Million
  • TABLE 45 North America Fecal Immunochemical Test (FIT) Market by Country, 2019 - 2022, USD Million
  • TABLE 46 North America Fecal Immunochemical Test (FIT) Market by Country, 2023 - 2030, USD Million
  • TABLE 47 North America Fecal Occult Blood Test (FOBT) Market by Country, 2019 - 2022, USD Million
  • TABLE 48 North America Fecal Occult Blood Test (FOBT) Market by Country, 2023 - 2030, USD Million
  • TABLE 49 North America Stool-DNA Test Market by Country, 2019 - 2022, USD Million
  • TABLE 50 North America Stool-DNA Test Market by Country, 2023 - 2030, USD Million
  • TABLE 51 North America Others Market by Country, 2019 - 2022, USD Million
  • TABLE 52 North America Others Market by Country, 2023 - 2030, USD Million
  • TABLE 53 North America Colorectal Cancer Screening Market by End-user, 2019 - 2022, USD Million
  • TABLE 54 North America Colorectal Cancer Screening Market by End-user, 2023 - 2030, USD Million
  • TABLE 55 North America Hospitals & Clinics Market by Country, 2019 - 2022, USD Million
  • TABLE 56 North America Hospitals & Clinics Market by Country, 2023 - 2030, USD Million
  • TABLE 57 North America Clinical Laboratories Market by Country, 2019 - 2022, USD Million
  • TABLE 58 North America Clinical Laboratories Market by Country, 2023 - 2030, USD Million
  • TABLE 59 North America Diagnostic Imaging Centres Market by Country, 2019 - 2022, USD Million
  • TABLE 60 North America Diagnostic Imaging Centres Market by Country, 2023 - 2030, USD Million
  • TABLE 61 North America Others Market by Country, 2019 - 2022, USD Million
  • TABLE 62 North America Others Market by Country, 2023 - 2030, USD Million
  • TABLE 63 North America Colorectal Cancer Screening Market by Country, 2019 - 2022, USD Million
  • TABLE 64 North America Colorectal Cancer Screening Market by Country, 2023 - 2030, USD Million
  • TABLE 65 US Colorectal Cancer Screening Market, 2019 - 2022, USD Million
  • TABLE 66 US Colorectal Cancer Screening Market, 2023 - 2030, USD Million
  • TABLE 67 US Colorectal Cancer Screening Market by Type, 2019 - 2022, USD Million
  • TABLE 68 US Colorectal Cancer Screening Market by Type, 2023 - 2030, USD Million
  • TABLE 69 US Colorectal Cancer Screening Market by Stool-based Type, 2019 - 2022, USD Million
  • TABLE 70 US Colorectal Cancer Screening Market by Stool-based Type, 2023 - 2030, USD Million
  • TABLE 71 US Colorectal Cancer Screening Market by End-user, 2019 - 2022, USD Million
  • TABLE 72 US Colorectal Cancer Screening Market by End-user, 2023 - 2030, USD Million
  • TABLE 73 Canada Colorectal Cancer Screening Market, 2019 - 2022, USD Million
  • TABLE 74 Canada Colorectal Cancer Screening Market, 2023 - 2030, USD Million
  • TABLE 75 Canada Colorectal Cancer Screening Market by Type, 2019 - 2022, USD Million
  • TABLE 76 Canada Colorectal Cancer Screening Market by Type, 2023 - 2030, USD Million
  • TABLE 77 Canada Colorectal Cancer Screening Market by Stool-based Type, 2019 - 2022, USD Million
  • TABLE 78 Canada Colorectal Cancer Screening Market by Stool-based Type, 2023 - 2030, USD Million
  • TABLE 79 Canada Colorectal Cancer Screening Market by End-user, 2019 - 2022, USD Million
  • TABLE 80 Canada Colorectal Cancer Screening Market by End-user, 2023 - 2030, USD Million
  • TABLE 81 Mexico Colorectal Cancer Screening Market, 2019 - 2022, USD Million
  • TABLE 82 Mexico Colorectal Cancer Screening Market, 2023 - 2030, USD Million
  • TABLE 83 Mexico Colorectal Cancer Screening Market by Type, 2019 - 2022, USD Million
  • TABLE 84 Mexico Colorectal Cancer Screening Market by Type, 2023 - 2030, USD Million
  • TABLE 85 Mexico Colorectal Cancer Screening Market by Stool-based Type, 2019 - 2022, USD Million
  • TABLE 86 Mexico Colorectal Cancer Screening Market by Stool-based Type, 2023 - 2030, USD Million
  • TABLE 87 Mexico Colorectal Cancer Screening Market by End-user, 2019 - 2022, USD Million
  • TABLE 88 Mexico Colorectal Cancer Screening Market by End-user, 2023 - 2030, USD Million
  • TABLE 89 Rest of North America Colorectal Cancer Screening Market, 2019 - 2022, USD Million
  • TABLE 90 Rest of North America Colorectal Cancer Screening Market, 2023 - 2030, USD Million
  • TABLE 91 Rest of North America Colorectal Cancer Screening Market by Type, 2019 - 2022, USD Million
  • TABLE 92 Rest of North America Colorectal Cancer Screening Market by Type, 2023 - 2030, USD Million
  • TABLE 93 Rest of North America Colorectal Cancer Screening Market by Stool-based Type, 2019 - 2022, USD Million
  • TABLE 94 Rest of North America Colorectal Cancer Screening Market by Stool-based Type, 2023 - 2030, USD Million
  • TABLE 95 Rest of North America Colorectal Cancer Screening Market by End-user, 2019 - 2022, USD Million
  • TABLE 96 Rest of North America Colorectal Cancer Screening Market by End-user, 2023 - 2030, USD Million
  • TABLE 97 Europe Colorectal Cancer Screening Market, 2019 - 2022, USD Million
  • TABLE 98 Europe Colorectal Cancer Screening Market, 2023 - 2030, USD Million
  • TABLE 99 Europe Colorectal Cancer Screening Market by Type, 2019 - 2022, USD Million
  • TABLE 100 Europe Colorectal Cancer Screening Market by Type, 2023 - 2030, USD Million
  • TABLE 101 Europe Colonoscopy Market by Country, 2019 - 2022, USD Million
  • TABLE 102 Europe Colonoscopy Market by Country, 2023 - 2030, USD Million
  • TABLE 103 Europe Stool-based Market by Country, 2019 - 2022, USD Million
  • TABLE 104 Europe Stool-based Market by Country, 2023 - 2030, USD Million
  • TABLE 105 Europe Colorectal Cancer Screening Market by Stool-based Type, 2019 - 2022, USD Million
  • TABLE 106 Europe Colorectal Cancer Screening Market by Stool-based Type, 2023 - 2030, USD Million
  • TABLE 107 Europe Fecal Immunochemical Test (FIT) Market by Country, 2019 - 2022, USD Million
  • TABLE 108 Europe Fecal Immunochemical Test (FIT) Market by Country, 2023 - 2030, USD Million
  • TABLE 109 Europe Fecal Occult Blood Test (FOBT) Market by Country, 2019 - 2022, USD Million
  • TABLE 110 Europe Fecal Occult Blood Test (FOBT) Market by Country, 2023 - 2030, USD Million
  • TABLE 111 Europe Stool-DNA Test Market by Country, 2019 - 2022, USD Million
  • TABLE 112 Europe Stool-DNA Test Market by Country, 2023 - 2030, USD Million
  • TABLE 113 Europe Others Market by Country, 2019 - 2022, USD Million
  • TABLE 114 Europe Others Market by Country, 2023 - 2030, USD Million
  • TABLE 115 Europe Colorectal Cancer Screening Market by End-user, 2019 - 2022, USD Million
  • TABLE 116 Europe Colorectal Cancer Screening Market by End-user, 2023 - 2030, USD Million
  • TABLE 117 Europe Hospitals & Clinics Market by Country, 2019 - 2022, USD Million
  • TABLE 118 Europe Hospitals & Clinics Market by Country, 2023 - 2030, USD Million
  • TABLE 119 Europe Clinical Laboratories Market by Country, 2019 - 2022, USD Million
  • TABLE 120 Europe Clinical Laboratories Market by Country, 2023 - 2030, USD Million
  • TABLE 121 Europe Diagnostic Imaging Centres Market by Country, 2019 - 2022, USD Million
  • TABLE 122 Europe Diagnostic Imaging Centres Market by Country, 2023 - 2030, USD Million
  • TABLE 123 Europe Others Market by Country, 2019 - 2022, USD Million
  • TABLE 124 Europe Others Market by Country, 2023 - 2030, USD Million
  • TABLE 125 Europe Colorectal Cancer Screening Market by Country, 2019 - 2022, USD Million
  • TABLE 126 Europe Colorectal Cancer Screening Market by Country, 2023 - 2030, USD Million
  • TABLE 127 Germany Colorectal Cancer Screening Market, 2019 - 2022, USD Million
  • TABLE 128 Germany Colorectal Cancer Screening Market, 2023 - 2030, USD Million
  • TABLE 129 Germany Colorectal Cancer Screening Market by Type, 2019 - 2022, USD Million
  • TABLE 130 Germany Colorectal Cancer Screening Market by Type, 2023 - 2030, USD Million
  • TABLE 131 Germany Colorectal Cancer Screening Market by Stool-based Type, 2019 - 2022, USD Million
  • TABLE 132 Germany Colorectal Cancer Screening Market by Stool-based Type, 2023 - 2030, USD Million
  • TABLE 133 Germany Colorectal Cancer Screening Market by End-user, 2019 - 2022, USD Million
  • TABLE 134 Germany Colorectal Cancer Screening Market by End-user, 2023 - 2030, USD Million
  • TABLE 135 UK Colorectal Cancer Screening Market, 2019 - 2022, USD Million
  • TABLE 136 UK Colorectal Cancer Screening Market, 2023 - 2030, USD Million
  • TABLE 137 UK Colorectal Cancer Screening Market by Type, 2019 - 2022, USD Million
  • TABLE 138 UK Colorectal Cancer Screening Market by Type, 2023 - 2030, USD Million
  • TABLE 139 UK Colorectal Cancer Screening Market by Stool-based Type, 2019 - 2022, USD Million
  • TABLE 140 UK Colorectal Cancer Screening Market by Stool-based Type, 2023 - 2030, USD Million
  • TABLE 141 UK Colorectal Cancer Screening Market by End-user, 2019 - 2022, USD Million
  • TABLE 142 UK Colorectal Cancer Screening Market by End-user, 2023 - 2030, USD Million
  • TABLE 143 France Colorectal Cancer Screening Market, 2019 - 2022, USD Million
  • TABLE 144 France Colorectal Cancer Screening Market, 2023 - 2030, USD Million
  • TABLE 145 France Colorectal Cancer Screening Market by Type, 2019 - 2022, USD Million
  • TABLE 146 France Colorectal Cancer Screening Market by Type, 2023 - 2030, USD Million
  • TABLE 147 France Colorectal Cancer Screening Market by Stool-based Type, 2019 - 2022, USD Million
  • TABLE 148 France Colorectal Cancer Screening Market by Stool-based Type, 2023 - 2030, USD Million
  • TABLE 149 France Colorectal Cancer Screening Market by End-user, 2019 - 2022, USD Million
  • TABLE 150 France Colorectal Cancer Screening Market by End-user, 2023 - 2030, USD Million
  • TABLE 151 Russia Colorectal Cancer Screening Market, 2019 - 2022, USD Million
  • TABLE 152 Russia Colorectal Cancer Screening Market, 2023 - 2030, USD Million
  • TABLE 153 Russia Colorectal Cancer Screening Market by Type, 2019 - 2022, USD Million
  • TABLE 154 Russia Colorectal Cancer Screening Market by Type, 2023 - 2030, USD Million
  • TABLE 155 Russia Colorectal Cancer Screening Market by Stool-based Type, 2019 - 2022, USD Million
  • TABLE 156 Russia Colorectal Cancer Screening Market by Stool-based Type, 2023 - 2030, USD Million
  • TABLE 157 Russia Colorectal Cancer Screening Market by End-user, 2019 - 2022, USD Million
  • TABLE 158 Russia Colorectal Cancer Screening Market by End-user, 2023 - 2030, USD Million
  • TABLE 159 Spain Colorectal Cancer Screening Market, 2019 - 2022, USD Million
  • TABLE 160 Spain Colorectal Cancer Screening Market, 2023 - 2030, USD Million
  • TABLE 161 Spain Colorectal Cancer Screening Market by Type, 2019 - 2022, USD Million
  • TABLE 162 Spain Colorectal Cancer Screening Market by Type, 2023 - 2030, USD Million
  • TABLE 163 Spain Colorectal Cancer Screening Market by Stool-based Type, 2019 - 2022, USD Million
  • TABLE 164 Spain Colorectal Cancer Screening Market by Stool-based Type, 2023 - 2030, USD Million
  • TABLE 165 Spain Colorectal Cancer Screening Market by End-user, 2019 - 2022, USD Million
  • TABLE 166 Spain Colorectal Cancer Screening Market by End-user, 2023 - 2030, USD Million
  • TABLE 167 Italy Colorectal Cancer Screening Market, 2019 - 2022, USD Million
  • TABLE 168 Italy Colorectal Cancer Screening Market, 2023 - 2030, USD Million
  • TABLE 169 Italy Colorectal Cancer Screening Market by Type, 2019 - 2022, USD Million
  • TABLE 170 Italy Colorectal Cancer Screening Market by Type, 2023 - 2030, USD Million
  • TABLE 171 Italy Colorectal Cancer Screening Market by Stool-based Type, 2019 - 2022, USD Million
  • TABLE 172 Italy Colorectal Cancer Screening Market by Stool-based Type, 2023 - 2030, USD Million
  • TABLE 173 Italy Colorectal Cancer Screening Market by End-user, 2019 - 2022, USD Million
  • TABLE 174 Italy Colorectal Cancer Screening Market by End-user, 2023 - 2030, USD Million
  • TABLE 175 Rest of Europe Colorectal Cancer Screening Market, 2019 - 2022, USD Million
  • TABLE 176 Rest of Europe Colorectal Cancer Screening Market, 2023 - 2030, USD Million
  • TABLE 177 Rest of Europe Colorectal Cancer Screening Market by Type, 2019 - 2022, USD Million
  • TABLE 178 Rest of Europe Colorectal Cancer Screening Market by Type, 2023 - 2030, USD Million
  • TABLE 179 Rest of Europe Colorectal Cancer Screening Market by Stool-based Type, 2019 - 2022, USD Million
  • TABLE 180 Rest of Europe Colorectal Cancer Screening Market by Stool-based Type, 2023 - 2030, USD Million
  • TABLE 181 Rest of Europe Colorectal Cancer Screening Market by End-user, 2019 - 2022, USD Million
  • TABLE 182 Rest of Europe Colorectal Cancer Screening Market by End-user, 2023 - 2030, USD Million
  • TABLE 183 Asia Pacific Colorectal Cancer Screening Market, 2019 - 2022, USD Million
  • TABLE 184 Asia Pacific Colorectal Cancer Screening Market, 2023 - 2030, USD Million
  • TABLE 185 Asia Pacific Colorectal Cancer Screening Market by Type, 2019 - 2022, USD Million
  • TABLE 186 Asia Pacific Colorectal Cancer Screening Market by Type, 2023 - 2030, USD Million
  • TABLE 187 Asia Pacific Colonoscopy Market by Country, 2019 - 2022, USD Million
  • TABLE 188 Asia Pacific Colonoscopy Market by Country, 2023 - 2030, USD Million
  • TABLE 189 Asia Pacific Stool-based Market by Country, 2019 - 2022, USD Million
  • TABLE 190 Asia Pacific Stool-based Market by Country, 2023 - 2030, USD Million
  • TABLE 191 Asia Pacific Colorectal Cancer Screening Market by Stool-based Type, 2019 - 2022, USD Million
  • TABLE 192 Asia Pacific Colorectal Cancer Screening Market by Stool-based Type, 2023 - 2030, USD Million
  • TABLE 193 Asia Pacific Fecal Immunochemical Test (FIT) Market by Country, 2019 - 2022, USD Million
  • TABLE 194 Asia Pacific Fecal Immunochemical Test (FIT) Market by Country, 2023 - 2030, USD Million
  • TABLE 195 Asia Pacific Fecal Occult Blood Test (FOBT) Market by Country, 2019 - 2022, USD Million
  • TABLE 196 Asia Pacific Fecal Occult Blood Test (FOBT) Market by Country, 2023 - 2030, USD Million
  • TABLE 197 Asia Pacific Stool-DNA Test Market by Country, 2019 - 2022, USD Million
  • TABLE 198 Asia Pacific Stool-DNA Test Market by Country, 2023 - 2030, USD Million
  • TABLE 199 Asia Pacific Others Market by Country, 2019 - 2022, USD Million
  • TABLE 200 Asia Pacific Others Market by Country, 2023 - 2030, USD Million
  • TABLE 201 Asia Pacific Colorectal Cancer Screening Market by End-user, 2019 - 2022, USD Million
  • TABLE 202 Asia Pacific Colorectal Cancer Screening Market by End-user, 2023 - 2030, USD Million
  • TABLE 203 Asia Pacific Hospitals & Clinics Market by Country, 2019 - 2022, USD Million
  • TABLE 204 Asia Pacific Hospitals & Clinics Market by Country, 2023 - 2030, USD Million
  • TABLE 205 Asia Pacific Clinical Laboratories Market by Country, 2019 - 2022, USD Million
  • TABLE 206 Asia Pacific Clinical Laboratories Market by Country, 2023 - 2030, USD Million
  • TABLE 207 Asia Pacific Diagnostic Imaging Centres Market by Country, 2019 - 2022, USD Million
  • TABLE 208 Asia Pacific Diagnostic Imaging Centres Market by Country, 2023 - 2030, USD Million
  • TABLE 209 Asia Pacific Others Market by Country, 2019 - 2022, USD Million
  • TABLE 210 Asia Pacific Others Market by Country, 2023 - 2030, USD Million
  • TABLE 211 Asia Pacific Colorectal Cancer Screening Market by Country, 2019 - 2022, USD Million
  • TABLE 212 Asia Pacific Colorectal Cancer Screening Market by Country, 2023 - 2030, USD Million
  • TABLE 213 China Colorectal Cancer Screening Market, 2019 - 2022, USD Million
  • TABLE 214 China Colorectal Cancer Screening Market, 2023 - 2030, USD Million
  • TABLE 215 China Colorectal Cancer Screening Market by Type, 2019 - 2022, USD Million
  • TABLE 216 China Colorectal Cancer Screening Market by Type, 2023 - 2030, USD Million
  • TABLE 217 China Colorectal Cancer Screening Market by Stool-based Type, 2019 - 2022, USD Million
  • TABLE 218 China Colorectal Cancer Screening Market by Stool-based Type, 2023 - 2030, USD Million
  • TABLE 219 China Colorectal Cancer Screening Market by End-user, 2019 - 2022, USD Million
  • TABLE 220 China Colorectal Cancer Screening Market by End-user, 2023 - 2030, USD Million
  • TABLE 221 Japan Colorectal Cancer Screening Market, 2019 - 2022, USD Million
  • TABLE 222 Japan Colorectal Cancer Screening Market, 2023 - 2030, USD Million
  • TABLE 223 Japan Colorectal Cancer Screening Market by Type, 2019 - 2022, USD Million
  • TABLE 224 Japan Colorectal Cancer Screening Market by Type, 2023 - 2030, USD Million
  • TABLE 225 Japan Colorectal Cancer Screening Market by Stool-based Type, 2019 - 2022, USD Million
  • TABLE 226 Japan Colorectal Cancer Screening Market by Stool-based Type, 2023 - 2030, USD Million
  • TABLE 227 Japan Colorectal Cancer Screening Market by End-user, 2019 - 2022, USD Million
  • TABLE 228 Japan Colorectal Cancer Screening Market by End-user, 2023 - 2030, USD Million
  • TABLE 229 India Colorectal Cancer Screening Market, 2019 - 2022, USD Million
  • TABLE 230 India Colorectal Cancer Screening Market, 2023 - 2030, USD Million
  • TABLE 231 India Colorectal Cancer Screening Market by Type, 2019 - 2022, USD Million
  • TABLE 232 India Colorectal Cancer Screening Market by Type, 2023 - 2030, USD Million
  • TABLE 233 India Colorectal Cancer Screening Market by Stool-based Type, 2019 - 2022, USD Million
  • TABLE 234 India Colorectal Cancer Screening Market by Stool-based Type, 2023 - 2030, USD Million
  • TABLE 235 India Colorectal Cancer Screening Market by End-user, 2019 - 2022, USD Million
  • TABLE 236 India Colorectal Cancer Screening Market by End-user, 2023 - 2030, USD Million
  • TABLE 237 South Korea Colorectal Cancer Screening Market, 2019 - 2022, USD Million
  • TABLE 238 South Korea Colorectal Cancer Screening Market, 2023 - 2030, USD Million
  • TABLE 239 South Korea Colorectal Cancer Screening Market by Type, 2019 - 2022, USD Million
  • TABLE 240 South Korea Colorectal Cancer Screening Market by Type, 2023 - 2030, USD Million
  • TABLE 241 South Korea Colorectal Cancer Screening Market by Stool-based Type, 2019 - 2022, USD Million
  • TABLE 242 South Korea Colorectal Cancer Screening Market by Stool-based Type, 2023 - 2030, USD Million
  • TABLE 243 South Korea Colorectal Cancer Screening Market by End-user, 2019 - 2022, USD Million
  • TABLE 244 South Korea Colorectal Cancer Screening Market by End-user, 2023 - 2030, USD Million
  • TABLE 245 Singapore Colorectal Cancer Screening Market, 2019 - 2022, USD Million
  • TABLE 246 Singapore Colorectal Cancer Screening Market, 2023 - 2030, USD Million
  • TABLE 247 Singapore Colorectal Cancer Screening Market by Type, 2019 - 2022, USD Million
  • TABLE 248 Singapore Colorectal Cancer Screening Market by Type, 2023 - 2030, USD Million
  • TABLE 249 Singapore Colorectal Cancer Screening Market by Stool-based Type, 2019 - 2022, USD Million
  • TABLE 250 Singapore Colorectal Cancer Screening Market by Stool-based Type, 2023 - 2030, USD Million
  • TABLE 251 Singapore Colorectal Cancer Screening Market by End-user, 2019 - 2022, USD Million
  • TABLE 252 Singapore Colorectal Cancer Screening Market by End-user, 2023 - 2030, USD Million
  • TABLE 253 Malaysia Colorectal Cancer Screening Market, 2019 - 2022, USD Million
  • TABLE 254 Malaysia Colorectal Cancer Screening Market, 2023 - 2030, USD Million
  • TABLE 255 Malaysia Colorectal Cancer Screening Market by Type, 2019 - 2022, USD Million
  • TABLE 256 Malaysia Colorectal Cancer Screening Market by Type, 2023 - 2030, USD Million
  • TABLE 257 Malaysia Colorectal Cancer Screening Market by Stool-based Type, 2019 - 2022, USD Million
  • TABLE 258 Malaysia Colorectal Cancer Screening Market by Stool-based Type, 2023 - 2030, USD Million
  • TABLE 259 Malaysia Colorectal Cancer Screening Market by End-user, 2019 - 2022, USD Million
  • TABLE 260 Malaysia Colorectal Cancer Screening Market by End-user, 2023 - 2030, USD Million
  • TABLE 261 Rest of Asia Pacific Colorectal Cancer Screening Market, 2019 - 2022, USD Million
  • TABLE 262 Rest of Asia Pacific Colorectal Cancer Screening Market, 2023 - 2030, USD Million
  • TABLE 263 Rest of Asia Pacific Colorectal Cancer Screening Market by Type, 2019 - 2022, USD Million
  • TABLE 264 Rest of Asia Pacific Colorectal Cancer Screening Market by Type, 2023 - 2030, USD Million
  • TABLE 265 Rest of Asia Pacific Colorectal Cancer Screening Market by Stool-based Type, 2019 - 2022, USD Million
  • TABLE 266 Rest of Asia Pacific Colorectal Cancer Screening Market by Stool-based Type, 2023 - 2030, USD Million
  • TABLE 267 Rest of Asia Pacific Colorectal Cancer Screening Market by End-user, 2019 - 2022, USD Million
  • TABLE 268 Rest of Asia Pacific Colorectal Cancer Screening Market by End-user, 2023 - 2030, USD Million